SOX2 and colorectal carcinoma: Zheng et al. have shown that the knockdown of SOX2 can substantially inhibit the Rho-ROCK signaling pathway, resulting in reduced tumor invasion, inhibited clonogenicity, and a decreased stemness of CRC cells [24].